Management options for litchi fruit & shoot borer, Conopomorpha sinensis: Prospects and challenges

2021 ◽  
Vol 29 (1) ◽  
pp. 46-50
Author(s):  
Kuldeep Srivastava ◽  
R.K. Patel ◽  
Sujeet Kumar ◽  
Sanjay Kumar Singh
Keyword(s):  
Management Options ◽  
Shoot Borer ◽  
Litchi Fruit

Management of litchi fruit and shoot borer, Conopomorpha sinensis using organic pesticides

2020 ◽  
pp. 213-218
Author(s):  
K. Srivastava ◽  
R.K. Patel ◽  
S.D. Pandey ◽  
A. Kumar ◽  
S.K. Singh ◽  
...  
Keyword(s):  
Shoot Borer ◽  
Litchi Fruit ◽  
Organic Pesticides

scholarly journals Evaluation of Insecticides for the Management of Litchi Fruit and Shoot Borer

2020 ◽  
Vol 6 ◽  
pp. 85-91
Author(s):  
Sudeep Kumar Upadhyay ◽  
Sunil Aryal ◽  
Bikash Bhusal ◽  
Bedanand Chaudhary
Keyword(s):  
Nutritive Value ◽  
Insect Pests ◽  
Insect Pest ◽  
Fruit Size ◽  
Fruit Crop ◽  
Shoot Borer ◽  
Severe Loss ◽  
Lambda Cyhalothrin ◽  
The One ◽  
Litchi Fruit

Litchi is an important subtropical evergreen fruit crop grown in Nepal, which have high nutritive value and refreshing taste. The Litchi growers are experiencing severe loss every year with the damage caused by several insect pests. Among them fruit and shoot borer Conopomorpha sinensis Bradley (Lepidoptera: Gracillariidae) is the one of the important insect pest. Experiments were conducted at RARS Tarahara on existing litchi orchard in RCBD design with four replication and five insecticides (Azadiractin, Chlorantraniliprole, Flubendiamide, Lambda cyhalothrin, and Dimethoate) with recommended doses in litchi orchard against C. sinensis during 2015 and 2016 AD to find out the efficient one. Among the tested insecticide chlorantraniliprole (18.5% w/w SC) and flubendiamide (39.35% m/m SC) each were found to be most efficient against C. sinensis and could be applied at the rate of 1 ml per 3 liter of water when fruit size was about pea and applied 3 times with 10 days interval.  This result suggested that these two insecticides could be used for the management for C. sinensis. Farmers may reduce the losses and increase their income with the application of these insecticides

Preventing Premature Weaning: Management Options for Common Lactation Conditions, Including OMT

2020 ◽  
pp. 20-25
Author(s):  
Denise Sackett ◽  
Tala Dajani ◽  
David Shoup ◽  
Uzoma Ikonne
Keyword(s):  
Postpartum Depression ◽  
Family Physician ◽  
Treatment Options ◽  
World Health ◽  
Management Options ◽  
Pharmacological Management ◽  
Control And Prevention ◽  
Lactational Mastitis ◽  
One Year ◽  
Health Organization

The benefits of breastfeeding are well established. The World Health Organization and the Centers for Disease Control and Prevention recommend that mothers breastfeed infants for at least one year, but most children are not breastfed that long because of many factors. Breastfeeding mothers face many challenges to continued breastfeeding, including medical conditions that arise during this period, such as postpartum depression and lactational mastitis. Because of a perceived lack of consistent guidance on medication safety, it can be difficult for the family physician to treat these conditions while encouraging mothers to continue breastfeeding. The purpose of the current review is to summarize and clarify treatment options for the osteopathic family physician treating lactating mothers. We specifically focus on the pharmacological management of contraception, postpartum depression, and lactational mastitis.

Advanced Management Options for Massive and Submassive Pulmonary Embolism

2016 ◽  
Vol 10 (1) ◽  
pp. 30 ◽  
Author(s):  
Sonika Malik ◽  
◽  
Anju Bhardwaj ◽  
Matthew Eisen ◽  
Sanjay Gandhi ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Vena Cava ◽  
Right Ventricular Dysfunction ◽  
Hemodynamic Instability ◽  
Adverse Outcomes ◽  
Intermediate Risk ◽  
Management Options ◽  
Vena Cava Filters ◽  
Submassive Pulmonary Embolism ◽  
Risk Patients

Pulmonary embolism (PE) is an important cause of morbidity and mortality and presents with significant diagnostic and therapeutic challenges. Clinical presentation ranges from mild, nonspecific symptoms to syncope, shock, and sudden death. Patients with hemodynamic instability and/ or signs of right ventricular dysfunction are at high risk for adverse outcomes and may benefit from aggressive therapy and support. Therapeutic anticoagulation is indicated in all patients in the absence of contraindications. Thrombolysis should be strongly considered in selected high- and intermediate-risk patients, either by systemic infusion or percutaneous catheter-directed therapy. Other therapeutic modalities, such as vena cava filters and surgical embolectomy, are options for patients who fail or cannot tolerate anticoagulation and/or thrombolysis. This article reviews the assessment and advanced management options for acute PE with focus on high- and intermediate-risk patients.

Sign in / Sign up

Export Citation Format

Share Document